Back
AVITA Medical 10K Form
Sell
8
RCEL
AVITA Medical
Last Price:
$7.33
Seasonality Move:
1.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RCEL News And Ratings
See the #1 stock for the next 7 days that we like better than RCEL
RCEL Financial Statistics
Sales & Book Value
| Annual Sales: | $64.3M |
|---|---|
| Cash Flow: | $-10.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.17 |
| Price / Book: | 40.83 |
Profitability
| EPS (TTM): | -2.19000 |
|---|---|
| Net Income (TTM): | $-57M |
| Gross Margin: | $55.2M |
| Return on Equity: | -415.55% |
| Return on Assets: | -68.64% |
AVITA Medical Earnings Forecast
Key AVITA Medical Financial Ratios
-
The Gross Profit Margin over the past 21 years for RCEL is 85.85%.
-
The Selling, General & Administrative Expenses for RCEL have been equal to 142.24% of Gross Profit Margin.
-
The Research & Development expenses have been 31.69% of Revenue.
-
The Net Earning history of RCEL is -96.26% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 13 years.
AVITA Medical Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RCEL |
| Website: | avitamedical.com |
Debt
| Debt-to-Equity Ratio: | -9.07 |
|---|---|
| Current Ratio: | 2.09 |
| Quick Ratio: | 1.65 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 18.64 |
RCEL Technical Analysis vs Fundamental Analysis
Sell
8
AVITA Medical (RCEL)
is a Sell
Is AVITA Medical a Buy or a Sell?
-
AVITA Medical stock is rated a SellThe current AVITA Medical [RCEL] share price is $7.25. The Score for RCEL is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.